Pediatricians Accelerate Childhood Therapies Act of 2023

Bill: 118-hr-4714
Sponsor: full_name: Rep. Joyce, John [R-PA-13]
Introduced: 2023-07-18
Policy area: Health
Subjects: Cancer

Child health

Congressional oversight

Drug, alcohol, tobacco use

Education programs funding

Genetics

Government information and archives

Health programs administration and funding

Higher education

Medical research

Mental health

Minority employment

Minority health

Research administration and funding

Women's employment

Women's health
Latest action: action_date: 2023-07-21
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2023-07-18
action_desc: Introduced in House
text: <p><b>Pediatricians Accelerate Childhood Therapies Act of 2023</b></p> <p>This bill requires the National Institutes of Health (NIH) to make awards to support early-career pediatric researchers. It also provides statutory authority for the NIH Pediatric Research Consortium to coordinate pediatric research across national health research institutions.</p>

tv_txt: I 118th CONGRESS 1st Session H. R. 4714 IN THE HOUSE OF REPRESENTATIVES July 18, 2023 Mr. Joyce of Pennsylvania (for himself and Ms. Schrier ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to authorize the Director of the National Institutes of Health to make awards to outstanding scientists, including physician-scientists, to support researchers focusing on pediatric research, including basic, clinical, translational, or pediatric pharmacological research, and for other purposes.

1. Short title This Act may be cited as the Pediatricians Accelerate Childhood Therapies Act of 2023 . 2. Trans-NIH Awards for Early-Career Pediatric Researchers Part G of title IV of the Public Health Service Act ( 42 U.S.C. 288 et seq. ) is amended by adding at the end the following new section: 489A. Trans-NIH Awards for Early-Career Pediatric Researchers (a) In general The Director of the NIH shall make awards to public and nonprofit entities to support outstanding scientists, including physician-scientists, to support early-career researchers focusing on pediatric research, including basic, clinical, translational, or pediatric pharmacological research. (b) Priority research populations In carrying out subsection (a), the Director of NIH may prioritize the issuance of awards to— (1) individual researchers at institutions described in subsection (a) presenting qualifying applications and representing populations that have been historically underrepresented in pediatric medical research, including women and underrepresented racial minorities; or (2) institutions of higher education that are eligible to receive funds under part A or B of title III of the Higher Education Act of 1965, part A or B of title V of such Act, or subpart 4 of part A of title VII of such Act, or research institutions partnering with such institutions of higher education to offer programs to support early-career pediatric researchers. (c) Priority research topic areas In carrying out subsection (a), the Director of NIH, in consultation with the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the directors of other national research institutes and national centers that participate within the NIH Pediatric Research Consortium, shall— (1) establish priority research topic areas, informed by external stakeholders, including research institutions, professional societies, patient advocacy organizations, and the private sector; and (2) consider opportunities to align such priority pediatric research topic areas with current and future priorities of the National Institutes of Health, including— (A) pediatric and adolescent mental and behavioral health, including addiction medicine; (B) childhood cancer; (C) precision medicine, genetics, and genomics; (D) rare diseases and disorders, such as sickle cell disease, and other diseases and disorders with significant unmet training needs; and (E) fetal, placental, and neonatal development. (d) Requirements The Director of NIH— (1) shall require recipients of awards under this section to use such awards to support pediatric research activities, including costs associated with laboratory staff and other costs associated with the conduct of research; and (2) may allow recipients of awards under this section to use such awards for costs associated with receiving guidance and training from senior researchers and mentors, as necessary to help such recipients reach a state of research independence, including conferences and other meeting participation. (e) Supplement, not supplant Awards made under this section shall be used to supplement, and not supplant, other funding for pediatric research and pediatric training. . 3. NIH Pediatric Research Consortium Title IV of the Public Health Service is amended by inserting after section 409D ( 42 U.S.C. 284h ) the following new section: 409D–1. NIH Pediatric Research Consortium (a) Establishment The Director of NIH shall establish and maintain a consortium to be known as the NIH Pediatric Research Consortium (in this section referred to as the Consortium ) to coordinate pediatric research programs across the National Institutes of Health. (b) Membership The members of the Consortium shall consist of representatives of multiple national research institutes and national centers. (c) Chair The Chair of the Consortium shall be the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (or the Director’s designee). (d) Duties In coordinating pediatric research programs across the National Institutes of Health, the Consortium shall— (1) establish new or confirm existing National Institutes of Health pediatric research priorities, including priorities involving multiple national research institutes or centers; (2) identify gaps and opportunities for research collaborations involving multiple national research institutes and national centers; and (3) identify opportunities to develop the next generation of pediatric researchers. (e) Consultation The Consortium shall consult regularly with external experts in the field of pediatric research, including children’s hospitals, children’s research institutions, patient organizations, and other stakeholders. (f) Reporting Beginning one year after the date of enactment of the Pediatricians Accelerate Childhood Therapies Act of 2023 and every 2 years thereafter, the Consortium shall submit to Congress, and make publicly available on the website of the National Institutes of Health, a report on— (1) any research project involving pediatrics and involving more than one Institute or Center that was supported during the review period; (2) any strategic initiatives that include proposed research activities focused on pediatrics; (3) career development awards supporting early-career researchers focused in pediatrics, including specific numbers of awards and amount of funding, made during the review period; (4) details on the composition of awards supporting early-career researchers, including deidentified, aggregate demographic data indicating the proportion of early-career researchers supported by the awards who are from populations that have been underrepresented in pediatric medical research; and (5) such other information as the Director of NIH determines appropriate. .